On the value and limitations of liver histology in assessing non-alcoholic steatohepatitis
- PMID: 32933780
- DOI: 10.1016/j.jhep.2020.07.020
On the value and limitations of liver histology in assessing non-alcoholic steatohepatitis
Conflict of interest statement
Conflict of interest JMS has acted as consultant to Intercept Pharmaceuticals, Genfit, Gilead Sciences, Novartis, Echosens, Pfizer, Roche, Siemens Healthineers and has received Research Funding from Gilead Sciences. BKS has nothing to disclose. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.J Hepatol. 2020 Dec;73(6):1322-1332. doi: 10.1016/j.jhep.2020.06.025. Epub 2020 Jun 28. J Hepatol. 2020. PMID: 32610115 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical